Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus Infection

This study was designed to test the efficacy of antiviral treatment with entecavir (ETV) in combination with DNA vaccines expressing duck hepatitis B virus (DHBV) antigens as a therapy for persistent DHBV infection in ducks. Ducks were inoculated with 10(9) DHBV genomes at 7 days of age, leading to...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Foster, Wendy K., Miller, Darren S., Marion, Patricia L., Colonno, Richard J., Kotlarski, Ieva, Jilbert, Allison R.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 2003
Предметы:	Antiviral Agents
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166090/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878529/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2624-2635.2003
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!